IL321783A - Crystalline forms of nlrp3 inflammasome inhibitors, chemical processes and chemical compounds - Google Patents

Crystalline forms of nlrp3 inflammasome inhibitors, chemical processes and chemical compounds

Info

Publication number
IL321783A
IL321783A IL321783A IL32178325A IL321783A IL 321783 A IL321783 A IL 321783A IL 321783 A IL321783 A IL 321783A IL 32178325 A IL32178325 A IL 32178325A IL 321783 A IL321783 A IL 321783A
Authority
IL
Israel
Prior art keywords
chemical
crystalline forms
nlrp3 inflammasome
inflammasome inhibitors
chemical compounds
Prior art date
Application number
IL321783A
Other languages
Hebrew (he)
Original Assignee
Astrazeneca Ab
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, Mitsubishi Tanabe Pharma Corp filed Critical Astrazeneca Ab
Publication of IL321783A publication Critical patent/IL321783A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL321783A 2022-12-28 2023-12-27 Crystalline forms of nlrp3 inflammasome inhibitors, chemical processes and chemical compounds IL321783A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263477516P 2022-12-28 2022-12-28
PCT/EP2023/087813 WO2024141534A1 (en) 2022-12-28 2023-12-27 Crystalline forms of nlrp3 inflammasome inhibitors, chemical processes and chemical compounds

Publications (1)

Publication Number Publication Date
IL321783A true IL321783A (en) 2025-08-01

Family

ID=89619412

Family Applications (1)

Application Number Title Priority Date Filing Date
IL321783A IL321783A (en) 2022-12-28 2023-12-27 Crystalline forms of nlrp3 inflammasome inhibitors, chemical processes and chemical compounds

Country Status (9)

Country Link
EP (1) EP4642763A1 (en)
JP (1) JP2026502218A (en)
KR (1) KR20250162767A (en)
CN (1) CN120435457A (en)
AU (1) AU2023417850A1 (en)
CL (1) CL2025001938A1 (en)
IL (1) IL321783A (en)
MX (1) MX2025007667A (en)
WO (1) WO2024141534A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250074627A (en) * 2023-11-20 2025-05-27 벤투스 테라퓨틱스 유에스 인코포레이티드 SOLID FREEBASE FORMS OF 5-chloro-2-(4-((2-hydroxy-2-methylpropyl)amino)pyrido[3,4-d]pyridazin-1-yl)phenol FOR INHIBITING NLRP3 AND USES THEREOF
TW202545527A (en) 2024-01-16 2025-12-01 英商諾得瑟拉公司 Nlrp3 and glp-1a combination therapies
CN120904042B (en) * 2025-07-22 2026-05-01 安徽医科大学 Azafeone derivative with liver ischemia reperfusion injury resisting activity, and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR119731A1 (en) 2019-05-17 2022-01-05 Novartis Ag NLRP3 INFLAMASOME INHIBITORS
TW202231281A (en) 2020-12-25 2022-08-16 大陸商上海拓界生物醫藥科技有限公司 A class of pyridazine containing compounds and medicinal uses thereof
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
PL4363406T3 (en) * 2021-07-02 2026-01-05 Astrazeneca Ab NLRP3 INFLAMASOME INHIBITORS

Also Published As

Publication number Publication date
MX2025007667A (en) 2025-12-01
AU2023417850A1 (en) 2025-08-14
KR20250162767A (en) 2025-11-19
WO2024141534A1 (en) 2024-07-04
CN120435457A (en) 2025-08-05
JP2026502218A (en) 2026-01-21
EP4642763A1 (en) 2025-11-05
CL2025001938A1 (en) 2026-01-16

Similar Documents

Publication Publication Date Title
IL318258A (en) Novel nlrp3 inflammasome inhibitors
SI4363406T1 (en) Nlrp3 inflammasome inhibitors
IL306022A (en) Inhibitors of nlrp3 inflammasome
IL318533A (en) Nlrp3 inflammasome inhibitors
IL307188A (en) Nlrp3 inhibitors
AU2023414924A1 (en) Heterocyclic and heteroaryl compounds as inhibitors of nlrp3
EP4349827A4 (en) Acid salt of crystalline csf-1r inhibitor, and preparation method therefor and use thereof
IL315457A (en) Solid forms, salts, and processes of preparation of a cdk2 inhibitor
AU2024255473A1 (en) Pyrazolopyrimidine derivatives as inhibitors of nlrp3
MX2025007667A (en) Crystalline forms of nlrp3 inflammasome inhibitors, chemical processes and chemical compounds
IL319011A (en) Triazinone derivatives as nlrp3 inhibitors
IL319009A (en) Triazinone derivatives as nlrp3 inhibitors
AU2024240240A1 (en) Urea derivatives for inhibiting nlrp3 and uses thereof
CA3278581A1 (en) Crystalline forms of nlrp3 inflammasome inhibitors, chemical processes and chemical compounds
AU2024238394A1 (en) Amide derivatives for inhibiting nlrp3 and uses thereof
HK40099180A (en) Inhibitors of nlrp3 inflammasome
HK40117000A (en) N-oxide inhibitors of nlrp3 inflammasome
TWI926416B (en) Inhibitor compounds for selective passivation of surfaces
PT4337652T (en) Nlrp3 inhibitors
HK40122493A (en) Nlrp3 inflammasome inhibitors
CA3280638A1 (en) Inhibitors of nlrp3
HK40128873A (en) Novel nlrp3 inflammasome inhibitors
HK40109676A (en) Inhibitors of nlrp3
CA3277202A1 (en) Heterocyclic and heteroaryl compounds as inhibitors of nlrp3
HK40129405A (en) Indazole and pyrazolopyridine compounds as inhibitors of nlrp3 inflammasome